1. Sequential treatment with afatinib and osimertinib in real-world patients with EGFR mutation-positive advanced NSCLC: the GioTag study. (January 2019) Authors: Hochmair, M.; Cufer, T.; Morabito, A.; Hao, D.; Ta Yang, C.; Soo, R.; Yang, J.; Gucalp, R.; Halmos, B.; Wang, L.; Golembesky, A.; Märten, A.; O'Byrne, K. Journal: Lung cancer Issue: Volume 127(2019)Supplement 1 Page Start: S59 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Sequential treatment with afatinib and osimertinib in real-world patients with EGFR mutation-positive advanced NSCLC: the GioTag study. (January 2019) Authors: Hochmair, M.; Cufer, T.; Morabito, A.; Hao, D.; Yang, C.; Soo, R.; Yang, J.C.; Rasim Gucalp, R.; Halmos, B.; Wang, L.; Golembesky, A.; Märten, A.; O'Byrne, K. Journal: Lung cancer Issue: Volume 127(2019)Supplement 1 Page Start: S37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The associations of CD4 count, CD4/CD8 ratio, and HIV viral load with survival from non-small cell lung cancer in persons living with HIV. Issue 8 (3rd August 2022) Authors: Klugman, M.; Fazzari, M.; Xue, X.; Ginsberg, M.; Rohan, T. E.; Halmos, B.; Hanna, D. B.; Shuter, J.; Hosgood, H. D. Journal: AIDS care Issue: Volume 34:Issue 8(2022) Page Start: 1014 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗